CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Gonzalo Carreño‐Tarragona, Nicholas C.P. Cross(University of Southampton), Caroline Alvares(University Hospital of Wales), María Luz Morales(Research Institute Hospital 12 de Octubre), Kathryn Goddard(Rotherham General Hospital), Ruth Stuckey(Hospital Universitario de Gran Canaria Doctor Negrín), Adam J. Mead(National Institute for Health and Care Research), Magda Alobaidi(Chelsea and Westminster Hospital NHS Foundation Trust), Deepti Radia(St Thomas' Hospital), Karan Mayani‐Mayani, Srinivasan Narayanan(University Hospital Southampton NHS Foundation Trust), Manuel Pérez‐Encinas(Complejo Hospitalario Universitario de Santiago), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Laura Rufián(Hospital Universitario 12 De Octubre), Elvira Mora, Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Isabel Cuenca(Hospital Universitario 12 De Octubre), Rodrigo Gil-Manso(Spanish National Cancer Research Centre), Xabier Gutiérrez(Hospital Universitario 12 De Octubre), Bethan Psaila(University of Oxford), José Carlos Martínez Ávila(Hospital Universitario La Paz), Peter P. Tóth(University of Debrecen), Andrew McGregor(Royal Sussex County Hospital), Marı́a Rozman(Universitat de Barcelona), Laura Moreno‐Galarraga(Navarre Institute of Health Research), Ioannis Koutsavlis(Western General Hospital), Teresa González‐Martínez(Complejo Hospitalario de Salamanca), Juan Carlos Hernández‐Boluda(Hospital Clínico Universitario de Valencia), Caroline P. Sweeney(Vale of Leven District General Hospital), Rosa Ayala(Hospital Universitario 12 De Octubre), Kerri Davidson(NHS Fife), Robert Cutting, Louisa McIlwaine(Glasgow Royal Infirmary), Paula Amat-Martínez(Hospital Clínico Universitario de Valencia), Lihui Wang(University of Liverpool), Vikram Singh(University of California San Diego), Jeffery Smith(Clatterbridge Cancer Centre NHS Foundation Trust), Adrián Segura(Hospital Universitario de Gran Canaria Doctor Negrín), Santiago Osorio(Institut Català d'Oncologia), José María Raya(Hospital Universitario de Canarias), Alberto Álvarez‐Larrán(Hospital Clínic de Barcelona), Sebastian Francis, Francisca Ferrer‐Marín(Centre for Biomedical Network Research on Rare Diseases)
Cited by 32
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k